Search - tctmd.com

Displaying 501 - 520 of 629

Sort: Relevancy | Date

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

May 24, 2017

News Daily News

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

May 04, 2017

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

News Daily News

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

April 19, 2017

Femoral Vascular Access and Closure (Manual and Device Based): A Step-by-Step Approach

Presentation Fellows 2017

Femoral Vascular Access and Closure (Manual and Device Based): A Step-by-Step Approach

Presenter: Manish A. Parikh, Zoltan G. Turi

April 07, 2017

Bleeding Complications Common and Costly After Transcatheter Therapies With Large-Bore Catheters

News Daily News

Bleeding Complications Common and Costly After Transcatheter Therapies With Large-Bore Catheters

March 30, 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

March 23, 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

TCTMD’s Top 10 Most Popular Stories for February 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

March 01, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

March 01, 2017

Does It Matter How Clot is Removed in Acute Ischemic Stroke? Maybe Not

News Conference News ISC 2017

Does It Matter How Clot Is Removed in Acute Ischemic Stroke? Maybe Not

February 22, 2017

News Industry News

Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke

February 21, 2017

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

News Daily News

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

February 17, 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

February 17, 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

February 15, 2017

News Industry News

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

February 13, 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

February 13, 2017

News Daily News

Abbott to Issue Urgent Recall of Certain Lots of Vascular Closure System

February 10, 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

February 07, 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

February 07, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.